All Together Now

Understanding the biological roots of cooperation might help resolve some of the biggest scientific challenges we face.

By | January 1, 2016

ANDRZEJ KRAUZEWhat a coincidence it is that The Scientist inaugurates 2016 with a feature entitled “The Evolution of Cooperation.” I am writing this editorial at the end of an extraordinary week during which two topics of prime interest to scientists have been the subject of international gatherings: the use of gene editing to manipulate human genomes and the adoption of measures to slow global warming. Cooperation among scientists, regulators, and governments is the only path to the resolution of these two complex issues.

The International Summit on Human Gene Editing met in Washington, DC, from December 1–3 to consider the scientific, medical, and ethical considerations surrounding the study and use of newly developed methods for altering human DNA. Much of the conversation involved the CRISPR/Cas method, a technique that has exploded over the last few years due to its relative simplicity and precision. Researchers are now using CRISPR-based protocols to manipulate human cells in the lab, and a growing number of biotech companies are champing at the bit to make CRISPR the next big thing in gene therapy. At the end of the conference, the organizing committee of 12 biologists, clinicians, and bioethicists issued a statement that endorses the use of the technique to repair somatic-cell mutations for clinical applications. For now, at least, the committee recommended limiting the editing of human embryos and gametes to basic research purposes only, and stressed the need for nations to cooperate in setting standards for therapeutic use of the method.

In the same week, contingents from nearly 200 nations have gathered in Paris for the 21st annual Conference of the Parties to the United Nations Framework Convention on Climate (COP21), a 12-day marathon in which attendees will attempt to agree on measures to cut carbon emissions. The need for cooperation is already abundantly evident. While government officials, not scientists, are doing the negotiating, the research community’s presence is obvious. “Unlike at previous climate talks, countries are coming to the table with science-backed contributions that challenge the business-as-usual approach,” writes climate researcher Eric Rehm, who traveled to Paris to support a positive outcome of the conference.

Here, Ford Denison and Katherine Muller examine cooperation’s role in the evolution of multicellularity, the influence of competition, and the pluses and minuses of cheating. “The key to harnessing such cooperative relationships is to understand them at the most basic biological levels. Continued research on within- and between-species cooperation will be nec­essary to make the most of our social world,” they write.

Antibiotics seriously mess with the cooperation between us and our gut microbiome. In our cover story, “Viral Soldiers,” Jyoti Madhusoodanan reports on the therapeutic use of viruses that infect specific bacteria—phages for short—to circumvent both the wholesale disruption of the microbiome by antibiotics and the enormous problem of antibiotic resistance. A 2014 review estimated that worldwide deaths from antibiotic resistance could total 10 million people per year by 2050. Phage treatments are not new and are available in some clinics overseas, but they may be due for a “second coming” in mainstream medicine if research into their efficacy pans out.

Next-generation sequencing has been a godsend to untangling the role of RNA epigenetics and has generated a plethora of new of research aimed at uncovering the functions of such marks. Transcriptome-wide mapping of the human genome has shown that the most prevalent transcript modification, methylation of adenosine at position N6, occurs at more than 12,000 sites in 7,000 coding genes and 250 noncoding regions. “Dysregulation of this modification has already been linked to obesity, cancer, and other human diseases,” write Dan Dominissini, Chuan He, and Gidi Rechavi, rounding out our first three feature articles for 2016.

We’ve got many more in store for you this year, our 30th. 


Mary Beth Aberlin  Editor-in-Chief

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: Alexandru

Alexandru

Posts: 92

January 1, 2016

Because The Scientist Magazine is un open door to the total knowledge (https://www.the-scientist.com/?articles.view/articleNo/38366/title/An-Open-Invitation/), and because God speculated the six genetically evolution crises to conduct Evolution in the established direction and because during in vitro fertilisation the genome builders eliminate Adam mtDNA (“the stone the builders rejected has become the cornerstone, a stone that causes people to stumble and a rock that makes them fall” - 1 Peter 2.7), please, do not forget Adam mtDNA in “the use of gene editing to manipulate human genomes” (from article), because the geneticists do not known what the in vitro man loses.

 

Happy new years!

Popular Now

  1. 2017 Top 10 Innovations
    Features 2017 Top 10 Innovations

    From single-cell analysis to whole-genome sequencing, this year’s best new products shine on many levels.

  2. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  3. Antiviral Immunotherapy Comes of Age
    News Analysis Antiviral Immunotherapy Comes of Age

    T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

  4. The Rising Research Profile of 23andMe
    News Analysis The Rising Research Profile of 23andMe

    An exploration of the genetics of earlobe attachment is just the latest collaborative research project to come out of the personal genetic testing company.

FreeShip